Graft Polymer (UK) PLC (GB:GPL) has released an update.
Graft Polymer (UK) PLC, a leader in biopolymer drug delivery systems, has announced the immediate resignation of Mr. Victor Bolduev, its CTO and board member. This follows a strategic shift to focus on healthcare opportunities and a collaboration with Awakn Life Sciences Corp, marked by the recent appointment of Professor David Nutt as Senior Scientific Adviser. The move aligns with the company’s divestiture of its industrial plastics division earlier this year.
For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.
